Clinical Trials Directory

Trials / Completed

CompletedNCT05103410

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

Impact of Preoperative Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy: A Randomized Controlled Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The analgesic effect of perioperative use of aripiprazole has not been fully investigated. So, this study aims to test the effects of aripiprazole versus placebo in reducing postoperative pain following laparoscopic hysterectomy and to explore the potential side effects.

Conditions

Interventions

TypeNameDescription
DRUGARIPiprazole 30 MGPatients will receive Aripiprazole 30 mg tablet orally 3 h before surgery
DRUGPlaceboPatients will receive placebo tablet which is identical in appearance, size, shape, and color to aripiprazole 3 h before surgery

Timeline

Start date
2021-11-10
Primary completion
2023-01-01
Completion
2023-01-10
First posted
2021-11-02
Last updated
2023-02-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05103410. Inclusion in this directory is not an endorsement.

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy (NCT05103410) · Clinical Trials Directory